Diferencia entre revisiones de «Template:Meningitis Antibiotics»
(Add Nafcillin, Ampicillin/Sulbactam, and Meropenem AntibioticDose entries)
 
(No se muestran 20 ediciones intermedias de 4 usuarios)
Línea 1: Línea 1:
''Treatment guidelines based on van de Beek et al''<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>
====Neonates (up to 1 month of age)<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>====
===Neonates (up to 1 month of age)===
{{Neonatal meningitis antibiotics}}
{{Neonatal meningitis antibiotics}}


===> 1 month to Adult===
====> 1 month old<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>====
*[[Ceftriaxone]] 2gm (50mg/kg) IV BID daily
{{Pediatric meningitis antibiotics}}
*[[Vancomycin]] 15-20 mg/kg IV BID daily '''PLUS'''
**'''[[Vancomycin]] is for resistant [[Pneumococcus]]'''


===Post Procedural (or penetrating trauma)===
====Adult < 50 yr<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>====
*[[Vancomycin]] 15-20mg/kg IV BID daily '''PLUS'''
{{Young adult meningitis antibiotics}}
*[[Cefepime]] 2g (50mg/kg) IV q8 hours daily '''OR''' [[Ceftazidime]] 2g (50mg/kg) IV q8 hours daily '''OR''' [[Meropenem]] 2gm (40mg/kg) IV q8 hours daily


====Adult > 50 yr and Immunocompromised<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>====
{{Elderly adult meningitis antibiotics}}


===[[Cryptococcosis]] Meningitis===
====Post Procedural (or penetrating trauma)<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>====
'''Options'''
*{{AntibioticDose|disease=Meningitis|drug=Vancomycin|dose=15-20mg/kg IV BID daily|context=Post-Procedural}} '''PLUS'''
*Amphotericin B 1mg/kg IV once daily '''AND''' Flucytosine 25mg/kg PO q6hrs daily
*{{AntibioticDose|disease=Meningitis|drug=Cefepime|dose=2g (50mg/kg) IV q8 hours daily|context=Post-Procedural}} '''OR''' [[Ceftazidime]] 2g (50mg/kg) IV q8 hours daily '''OR''' [[Meropenem]] 2gm (40mg/kg) IV q8 hours daily
*Amphotericin B 5mg/kg IV once daily '''AND''' Flucytosine 25mg/kg PO q6hrs daily


====[[Cryptococcosis]] Meningitis====
{{Crypto meningitis antibiotics}}


===[[Neisseria meningitidis]] Prophylaxis===
====Meningitis with severe PCN allergy====
*[[Ceftriaxone]] 250mg IM once (if less than 15yr then 125mg IM)
{{Meningitis peniccillin allergic antibiotics}}
*[[Ciprofloxacin]] 500mg PO once
*[[Rifampin]] 600 mg PO BID x 2 days
** if < 1 month old then 5mg/kg PO BID x 2 days
** if ≥ 1 month old then 10mg/kg (max at 600mg) PO BID x 2 days


===Meningitis with severe PCN allergy===
====Meningitis with VP shunt====
*[[Chloramphenicol]] 1g IV q6h + [[Vancomycin]] 15mg/kg q8-12hr
*Coverage for skin contaminants ([[S. epidermis]], [[S. aureus]])
*[[Vancomycin]] plus [[ceftriaxone]] plus shunt removal


===Age >50y===
===[[Neisseria meningitidis]] Prophylaxis===
*[[Ceftriaxone]] 2gm IV q12hr + [[Vancomycin]] 15mg/kg q8-12hr + [[Ampicillin]] 2gm IV q4h
{{Neisseria meningitis prophylaxis}}
*{{AntibioticDose|drug=Ampicillin/Sulbactam|dose=400mg ampicillin/kg/day IM/IV divided q6 hours; First Dose: 100mg ampicillin/kg IM/IV x 1 (150mg Unasyn/kg IM/IV x 1); Max: 2000mg ampicillin (3000mg Unasyn) per DOSE|context=Meningitis|disease=Meningitis|population=Pediatric}}
*{{AntibioticDose|drug=Meropenem|dose=2g IV every 8 hours.|context=Meningitis|disease=Meningitis|population=Adult}}
*{{AntibioticDose|drug=Nafcillin|dose=100-200mg/kg/day IV divided q4-6h; Max: 12 g/day|context=Bacterial Meningitis|disease=Meningitis|population=Adult}}

Revisión actual - 10:53 20 mar 2026

Neonates (up to 1 month of age)[1]

MRSA is uncommon in the neonate

  • Ampicillin 75mg/kg IV q6hrs PLUS
  • Cefotaxime 50mg/kg IV q6hrs OR 2.5mg/kg IV q8hrs
    • Per AAP, ceftazidime 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups[2]
  • If suspecting S. pneumoniae or MRSA, add standard neonatal dosing
  • Consider acyclovir for HSV

> 1 month old[3]

Alternatives (e.g. penicillin/cephalosporin allergy):

Adult < 50 yr[4]

Adult > 50 yr and Immunocompromised[5]

Post Procedural (or penetrating trauma)[7]

Cryptococcosis Meningitis

Options

  • Amphotericin B 1mg/kg IV once daily AND Flucytosine 25mg/kg PO q6hrs daily
  • Amphotericin B 5mg/kg IV once daily AND Flucytosine 25mg/kg PO q6hrs daily

Meningitis with severe PCN allergy

Meningitis with VP shunt

Neisseria meningitidis Prophylaxis

  • Ceftriaxone 250mg IM once
  • Ceftriaxone 125mg IM once (if <=15yr)
  • Ciprofloxacin 500mg PO once
  • Rifampin 600 mg PO BID x 2 days
  • Rifampin <1mo: 5mg/kg PO BID x 2 days; >=1mo: 10mg/kg PO BID x 2 days
  • Ampicillin/Sulbactam 400mg ampicillin/kg/day IM/IV divided q6 hours; First Dose: 100mg ampicillin/kg IM/IV x 1 (150mg Unasyn/kg IM/IV x 1); Max: 2000mg ampicillin (3000mg Unasyn) per DOSE
  • Meropenem 2g IV every 8 hours.
  • Nafcillin 100-200mg/kg/day IV divided q4-6h; Max: 12 g/day
  1. ↑ van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702
  2. ↑ https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1
  3. ↑ van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702
  4. ↑ van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702
  5. ↑ van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702
  6. ↑ [Guideline] Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul. 15(7):649-59.
  7. ↑ van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702
Obtenido de «https://www.wikem.org/w/index.php?title=Template:Meningitis_Antibiotics&oldid=386656»